CCL2 and lung carcinoma: Based on these results, we may surmise that CCL11 and IP-10 are specifically increased in plasma from pulmonary tuberculosis and tuberculous pleurisy patients, while CCL8 and CCL2 are specifically decreased when compared with lung cancer controls.